Stomach Cancer Recurrent: Clinical Trials

3 trials for Stomach Cancer Recurrent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1
Not applicable1Recruiting 1
Phase 11Recruiting 1

Follow Stomach Cancer Recurrent: new trials by email Literature Review of Stomach Cancer Recurrent trials Research Report on Stomach Cancer Recurrent

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TR115 in ARID1A-Mutated Advanced Solid Tumors
TR115 - Ovarian Clear Cell Carcinoma, Endometrial Cancer
Phase 2Not yet recruitingTarapeutics Science Inc.502026-09-202026-08-28
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine - Stomach Cancer, Stomach Cancer Recurrent
Phase 1 / Phase 2RecruitingEssen Biotech752024-09-102024-11-12
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
PICO G2 4k - Cancer Pain, Visceral Pain
Not applicableRecruitingCedars-Sinai Medical Center3602021-10-052026-11-12

Narrower conditions

Esophageal Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Anus Neoplasms (1)  ·  Appendiceal Neoplasms (1)  ·  Bile Duct Neoplasms (1)  ·  Biliary Tract Neoplasms (1)  ·  Cancer Pain (1)  ·  Carcinoid Tumor (1)  ·  Colonic Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Esophageal Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Head and Neck Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Stomach Diseases (2)  ·  Adenocarcinoma (1)  ·  Anus Diseases (1)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)

Interventions

Cyclophosphamide (1)  ·  Interleukin-2 (1)  ·  fludarabine (1)  ·  pembrolizumab (1)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Essen Biotech (1)  ·  Tarapeutics Science Inc. (1)

Countries

China (2)  ·  United States (1)

Top investigators

Brennan Spiegel, MD, MSHS (1)  ·  Scott Irwin, MD, PhD (1)

NIH funding

R01CA252211 (1)